Related Experiment Videos

Gene therapy with AdV-IL2 (TG 1021) in unresectable digestive adenocarcinoma. Phase I-II study, first inclusions

F N Gilly1, A C Sayag-Beaujard, J Bienvenu

  • 1Surgical Department, CHLS, Lyon Pierre Bénite, France. francogi@uheim.univ-lyon1.fr

Advances in Experimental Medicine and Biology
|February 23, 1999
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos